Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-08

Clinical Trial Update: Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update on piperacillin sodium and sulbactam sodium for respiratory and urinary tract infections completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) (piperacillin and sulbactam)

Snippet

Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd | Conditions: Respiratory Tract Infections, Urinary Tract Infections | Phase 4 | Status: COMPLETED